Gambogic acid potently induces apoptosis in aortic smooth muscle cells through a caspase-dependent pathway, showing greater efficacy than simvastatin in vitro.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; leaves open further preclinical testing of gambogic acid in vascular disease models.
Gambogic acid (GA) has powerful apoptotic actions. The authors investigated whether GA has effects on aortic smooth muscle cells, and compared its potency with that of simvastatin. muscle cells were isolated from the aortas of Sprague-Dawley rats (4-6 week). Cell purities were confirmed IF staining using α-smooth muscle actin antibody. The IC50 values for cell death by GA and simvastatin determined using a MTT assay, and the apoptotic effects of 1 μM GA or 30 μM simvastatin (concentrations to IC50 values) were determined after 24 h of treatment using live cell images and by FITC annexin-V propidium iodide double-staining. In addition, western blotting was used to evaluate apoptosis by quantifying in the expression levels of the PARP and procaspase-3 as well as cleavages of PARP and procaspase-3 treatment with 1 μM GA or 30 μM simvastatin. The IC50 of GA (1 μM) was lower than that of simvastatin(30 μM). Cell numbers were markedly reduced by both drugs in live cell images. GA (1 μM) produced a higher of apoptosis than 30 μM simvastatin (26.4±2.37% vs. 8.3±1.54%, respectively; P⁄0.05, n=3) by FITC-V & PI double-staining. In addition, 1 μM GA reduced the expressions of PARP, procaspase-3, and Mcl-1 in cells, whereas 30 μM simvastatin did not. Pretreatment with z-VAD-fmk attenuated GA-induced apoptosis the cleavages of PARP and procaspase-3. The decreased level of Mcl-1 protein induced by GA treatment was by z-VAD-fmk. results indicate that GA-induced apoptosis was mediated by a caspase-dependent pathway.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: